NC
GILD icon

Northpointe Capital’s Gilead Sciences GILD Stock Holding History

Northpointe Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-34,261
Closed -$2.45M – 174
2017
Q4 		$2.45M Buy
+34,261
New +$2.6M 0.28% 150
2015
Q2 		– Sell
-18,463
Closed -$1.81M – 208
2015
Q1 		$1.81M Sell
18,463
-7,099
-28% -$721K 0.2% 162
2014
Q4 		$2.41M Buy
25,562
+2,212
+9% +$229K 0.29% 122
2014
Q3 		$2.49M Buy
23,350
+127
+0.5% +$12.4K 0.26% 112
2014
Q2 		$1.93M Buy
23,223
+9,493
+69% +$739K 0.19% 155
2014
Q1 		$972K Buy
+13,730
New +$1.08M 0.1% 195
2013
Q4 		– Sell
-12,743
Closed -$801K – 242
2013
Q3 		$801K Buy
12,743
+3,183
+33% +$190K 0.09% 198
2013
Q2 		$490K Buy
+9,560
New +$498K 0.06% 187

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Northpointe Capital's GILD Position: Q1 2018 in Review

Northpointe Capital sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 34,261 shares — an estimated $2.45M sold.

Northpointe Capital first reported a position in GILD in Q2 2013 and held it in 8 quarters. The position peaked at $2.49M in Q3 2014. 1,563 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

  • Northpointe Capital reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
  • Northpointe Capital sold 34,261 Gilead Sciences shares in Q1 2018, an estimated $2.45M.
  • Northpointe Capital first reported a position in Gilead Sciences in Q2 2013 and held it in 8 quarters.
  • Northpointe Capital's Gilead Sciences position peaked at $2.49M in Q3 2014.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on Northpointe Capital's 13F filing for Q1 2018, filed 11 Apr 2018.